Kim Sablich
Executive Vice President and General Manager, North America
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $632,412 | $4,165,304 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $606,146 | $4,303,200 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and General Manager, US | $566,923 | $3,947,509 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | Executive Vice President and General Manager, US | $327,885 | $4,621,245 |
Earnings-call appearances
-
Jazz Pharmaceuticals plc Q3 FY2023 Earnings Call2023-11-08
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q2 FY2023 Earnings Call2023-08-09
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2023 Earnings Call2023-05-10
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2022 Earnings Call2023-03-01
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2022 Earnings Call2022-11-09
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q2 FY2022 Earnings Call2022-08-03
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2022 Earnings Call2022-05-04
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2021 Earnings Call2022-03-01
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2021 Earnings Call2021-11-09
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2021 Earnings Call2021-04-20
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2020 Earnings Call2021-02-23
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2020 Earnings Call2020-11-02
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q2 FY2020 Earnings Call2020-08-04
Jazz Pharmaceuticals plc (JAZZ)